Characterization of prostate cancer missed by sextant biopsy.
暂无分享,去创建一个
[1] M. Terris,et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. , 1989, The Journal of urology.
[2] M. Terris,et al. Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies. , 1992, The Journal of urology.
[3] A S Whittemore,et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.
[4] P. Walsh,et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.
[5] W. Catalona,et al. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values. , 1995, The Journal of urology.
[6] T. Stamey,et al. Making the most out of six systematic sextant biopsies. , 1995, Urology.
[7] W. Ellis,et al. Repeat prostate needle biopsy: who needs it? , 1995, The Journal of urology.
[8] John T. Wei,et al. The influence of prostate size on cancer detection. , 1995, Urology.
[9] W. Catalona,et al. Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies. , 1996, The Journal of urology.
[10] V. Reuter,et al. Clinical significance of repeat sextant biopsies in prostate cancer patients. , 1997, Urology.
[11] P. Walsh,et al. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. , 1997, The Journal of urology.
[12] W. Fair,et al. Indications for transition zone biopsy in the detection of prostatic carcinoma. , 1997, The Journal of urology.
[13] L. Holmberg,et al. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. , 1997, Urology.
[14] D L McCullough,et al. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. , 1997, The Journal of urology.
[15] D. Chan,et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. , 1998, The Journal of urology.
[16] P. Humphrey,et al. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study. , 1998, Urology.
[17] W. Fair,et al. Incidence and clinical significance of false-negative sextant prostate biopsies. , 1998, The Journal of urology.
[18] D. Johnston,et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. , 2000, The Journal of urology.
[19] C. Amling,et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. , 2000, The Journal of urology.
[20] J. Epstein,et al. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? , 2001, The Journal of urology.
[21] M. Tobias-Machado,et al. TWELVE CORE PROSTATE BIOPSY VERSUS SIX SYSTEMATIC SEXTANT BIOPSIES , 2002 .
[22] Alicia Samuels,et al. Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.